Phase IIIAndrogen Modulator
Compound 61472
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061472
Risk Class
HIGH
Last Audit
Feb 26, 2108
Research Abstract
Androgen Modulator candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61472 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061472 with updates logged 2108-02-26.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61472Androgen Modulator Program 61472
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061472
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61472